Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin in Paracentesis for ACLF
NCT02467348Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Mar 2015
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in acute-on-chronic liver failure (ACLF) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Incidence of Paracentesis Induced Circulatory Dysfunction at 1 year. Started Mar 2015; status: completed.
02
Drugs
albumin (human)
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT02467348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467348.